Disease/Infection News

RSS

Eradicating malaria is a 'realistic possibility'

Eliminating malaria in endemic countries is a "realistic possibility if those countries keep expanding malaria prevention and treatment at the pace set in recent years," Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, writes on the Bill & Melinda Gates Foundation's blog.

23 Jun 2011

LPI receives final FDA approval for generic version of Levaquin tablets

Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of Ortho McNeil's Levaquin tablets.

23 Jun 2011

Tobira commences cenicriviroc Phase IIb clinical trial for HIV infection

Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).

22 Jun 2011

First Edition: June 22, 2011

Today's headlines include an exclusive AP report detailing a "twist" in the health law that would allow millions of middle class Americans -- mainly early retirees -- access to Medicaid.

22 Jun 2011

Elsevier introduces new open-access journal on parasitology

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, in association with the Australian Society for Parasitology, is pleased to announce the launch of a new journal, International Journal for Parasitology: Drugs and Drug Resistance.

22 Jun 2011

Ghana's vice president discusses country's efforts to fight HIV/AIDS

John Dramani Mahama, vice president of the Republic of Ghana, recently spoke with NPR's "Tell Me More" about how Ghana has made significant gains against HIV/AIDS, bringing the prevalence rate down to 1.5 percent from nearly 4 percent.

22 Jun 2011

'Steadfast focus' needed in fight against HIV/AIDS

Recapping the 30-year history of HIV/AIDS from an USAID perspective, Administrator Rajiv Shah writes in this "Impact blog" post, "Our work is far from done. We have a shared responsibility as a global partner to save lives by focusing on smart investments. The generosity of the American people has made sustained progress against this deadly disease possible. Closing the chapter on HIV/AIDS will require a steadfast focus on remaining gaps and challenges as we chart the way forward".

22 Jun 2011

Pharmasset receives U.S. patent titled 'Nucleoside Phosphoramidate Prodrugs'

Pharmasset, Inc. announces that the United States Patent and Trademark Office has issued U.S. patent 7,964,580 titled "Nucleoside Phosphoramidate Prodrugs".

22 Jun 2011

WHO releases first-ever HIV guidelines for MSM and transgender people

The WHO on Tuesday released its first-ever HIV guidelines on men who have sex with men (MSM) and transgender people, which "urges governments to ensure gay men get equal access to HIV prevention and treatment services," the Associated Press reports.

22 Jun 2011

Rapid diagnostic tests for malaria can be improved, says researcher

Rapid diagnostic tests for malaria are simple, reliable and robust. But errors occur, through misuse or because they aren't designed for primitive circumstances. Researcher Philippe Gillet put them to the test and made a series of suggestions for improvement. It resulted in a PhD at the Institute of Tropical Medicine Antwerp and Maastricht University.

22 Jun 2011

Scientists apply math model to HIV to discover targets for vaccines or drugs

Scientists at the Ragon Institute - a joint enterprise of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed in 2009 to bring together diverse disciplines to work on HIV - "using a powerful mathematical tool previously applied to the stock market have identified an Achilles heel in HIV that could be a prime target for AIDS vaccines or drugs," the Wall Street Journal reports.

22 Jun 2011

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase Ib clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus (HCV) infection.

22 Jun 2011

Results of African malaria vaccine trial expected later this year

The final phase of testing for GlaxoSmithKline Biologicals' malaria vaccine, RTS,S, is underway in seven sub-Saharan African countries, and "if the results, due to be released later this, year confirm the vaccine's efficacy in preventing malaria, it could be made available as early as 2015," IRIN reports.

22 Jun 2011

Rats help tackle humanitarian issues

John Campbell, a senior fellow for Africa Policy Studies at the Council on Foreign Relations, writes about "HeroRATs" in this CFR blog post.

22 Jun 2011

New study offers detailed look at the status of Lyme disease in Central Illinois

A new study offers a detailed look at the status of Lyme disease in Central Illinois and suggests that deer ticks and the Lyme disease bacteria they host are more adaptable to new habitats than previously appreciated.

22 Jun 2011

Poll: Few parents fully understand their role in preventing infections at water parks

Water parks offer families a chance to have fun and be physically active. That fun may come with the risk of getting sick with infections from the water, illnesses that affect over 10,000 Americans each year. One of the best ways to reduce the risk of infection is to make sure that parents and kids shower before playing at water parks.

21 Jun 2011

Do not overlook people with disabilities in HIV prevention efforts

Winstone Zulu, an adviser for AIDS-Free World and the coordinator of Health Triangle Zambia who walks with crutches because of a polio infection as a child, writes in a New York Times opinion piece that people with disabilities are rarely exposed to sex education and are almost never considered in need of information about H.I.V. and treatment for it.

21 Jun 2011

IPS examines U.N. Security Council's dealings with 'non-security' issues

Inter Press Service examines the changing scope of the U.N. Security Council.

21 Jun 2011

IPS examines access to treatment for drug-resistant TB

"Access to treatment for drug-resistant tuberculosis remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs," Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low "has led to skyrocketing prices."

21 Jun 2011